I

Incyte

Biopharmaceutical company pursuing drug discovery.

Senior Scientist Downstream Processing

Bioprocess & BiomanufacturingUpdated on Nov 10
Full-timeYverdon-les-Bains, SwitzerlandNo salary listedIn-person

About the Job

Requirements

  • An MSc or equivalent degree in biotechnology, biochemistry, chemical engineering, pharmaceutical sciences, or a related scientific discipline.
  • Significant experience in biopharmaceutical manufacturing, MSAT, process development, or technology transfer, preferably involving downstream processing in a GMP environment.
  • Strong scientific expertise in downstream manufacturing processes and associated equipment.
  • Demonstrated ability to solve complex technical problems using a structured, data-driven, and scientific approach.
  • Proficiency in statistical tools and data analysis, including design of experiments (DOE) and multifactorial analysis.
  • Experience with risk assessment methodologies such as failure mode and effects analysis (FMEA).
  • Strong understanding of GMP requirements and relevant regulatory expectations for biopharmaceutical manufacturing.
  • Ability to write clear, structured, and scientifically sound technical documentation.
  • Ability to interpret scientific literature and apply relevant knowledge to process understanding and problem solving.
  • Proven ability to contribute to investigations, change controls, validation documentation, and process performance assessments.
  • Ability to lead cross-functional troubleshooting and drive alignment on technical actions.
  • Strong project and task prioritization skills.
  • Ability to work effectively with Production, QA, QC, Engineering, and Process Science.
  • Commitment to compliance, business integrity, and ethical behavior.

Responsibilities

  • Own and lead downstream process technology transfers for new products introduced at the Yverdon Bioplant.
  • Assess facility fit, process scalability, equipment capability, and operational readiness for incoming downstream processes.
  • Serve as the downstream subject matter expert during new product introduction implementation and ensure phase-appropriate process knowledge is transferred to Manufacturing.
  • Provide downstream process expertise to Production during GMP manufacturing campaigns.
  • Lead technical troubleshooting for complex downstream process issues and define science-based actions with relevant stakeholders.
  • Lead or support major GMP investigations related to downstream process performance, deviations, and process-related events.
  • Ensure downstream process descriptions remain current, accurate, and aligned with manufacturing execution.
  • Support and review manufacturing execution system (MES) master data and batch record configuration to ensure alignment with approved process descriptions.
  • Own or contribute to DSP technology transfer reports, campaign reports, risk assessments, and process-related GMP documentation.
  • Represent Manufacturing Technology in risk assessments with Process Science, Production, QA, QC, and Engineering.
  • Lead process improvement initiatives to increase robustness, improve capacity, or reduce cost of goods.
  • Maintain close interactions with Global Process Science teams in Yverdon and the United States.
  • Act as the operational and scientific referent for downstream process topics within the assigned scope.

Desired Qualifications

  • Experience with downstream processing in a GMP environment is preferred.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs